Clinical Trials Directory

Trials / Completed

CompletedNCT04843748

Clinical Evaluation Study for Assessing the Visual Performance of Hanita Lenses Trifocal IOL

Clinical Study for Assessing the Visual Performance of Hanita Lenses New Trifocal Intraocular Lens

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Hanita Lenses · Industry
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Hanita Lenses Trifocal IOL, SeeLens AFR (Intensity IOL).Prospective, single-arm single-center, open-label study.

Detailed description

Device: Hanita Lenses Trifocal IOL, SeeLens AFR (Intensity IOL). Indication studied: The Hanita Lenses Trifocal IOL is intended for implantation in the capsular bag in the posterior chamber in order to replace the crystalline lens of the eye to attain visual correction of aphakia in adult patients in whom a cataractous lens has been removed, who desire improved uncorrected vision, useful near and intermediate visual functions, and reduced spectacle dependence. Study description: This study is a prospective, single-arm single-center, open-label study.

Conditions

Interventions

TypeNameDescription
DEVICEcataract surgery and intraocular lens implantation - both eyescataract surgery and intraocular lens implantation for both eyes

Timeline

Start date
2018-08-18
Primary completion
2021-01-06
Completion
2021-01-06
First posted
2021-04-14
Last updated
2021-04-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04843748. Inclusion in this directory is not an endorsement.

Clinical Evaluation Study for Assessing the Visual Performance of Hanita Lenses Trifocal IOL (NCT04843748) · Clinical Trials Directory